Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Natalizumab treatment decreases serum IgM and IgG levels in multiple sclerosis patients.
Alemtuzumab and multiple sclerosis: therapeutic application.
A full genome search in multiple sclerosis.
Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis.
Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells.
A genetic screen identifies genes essential for development of myelinated axons in zebrafish.
Teriflunomide (Aubagio) approved for use by the NHS in Scotland and Northern Ireland
Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators.
Drug Safety Labeling Changes
Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis.
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.
Interferon beta for secondary progressive multiple sclerosis.
Impact of MS during the critical window of brain development.
Stopping Disease Modifying Therapy in Progressive Multiple Sclerosis - A Prospective Study
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.
Antigen-specific tolerance by autologous myelin Peptide-coupled cells: a phase 1 trial in multiple sclerosis.
The immunopathology of multiple sclerosis: an overview.
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis
Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders.
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
Safety and efficacy of mitoxantrone in pediatric patients with aggressive multiple sclerosis.
New insights into signaling during myelination in zebrafish.
Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults.
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.

Pages